Christof SCHAFAUER

En résumé

Entreprises

• Stago - Manager R&D - Point-of-Care

  Asnières-sur-Seine 2017 - maintenant The Stago Group is the world leader in Haemostasis and Thrombosis and expanding the product portfolio to Easy-To-Use Portable Blood Analyser, also known as Point of care (POC) testing. POC testing devices employed remotely enable doctors to see in near-real time vital information about their patients outside of a laboratory setting. The implementation of POC testing is useful for value-based healthcare where there is a need for more convenient diagnosis, accurate monitoring, early detection and the prevention and management of chronic conditions.
  My mission is to put on the market innovative Point-of-care testing products that address the clinical issues of haemostasis and to ensure the most cost-effective performance of our R&D department by shorten the time to market.

• Mauna Kea Technologies - Directeur R&D - Hardware & Consommables

  Paris 2012 - 2017 Mauna Kea Technologies is a development –stage company designing revolutionary, light-based, non-invasive medical technologies and devices to facilitate early diagnosis of major human diseases such as cancer, heart diseases or ophthalmologic pathologies. These instruments use perfectly harmless visible or infrared light and are thus part of what is now commonly referred to as “biomedical imaging”. MKT’s first focus for the medical market is an adjunct medical device capable of in vivo cellular imaging and specifically designed for optical biopsy or biopsy guidance via endoscopy.

• Karl Storz GmbH - Product & Program Manager - Gastrointestinal Endoscopy

  2012 - 2012 Managing complex product development projects in the progressing area of gastroenterology: Flexible Videoscopes, Imaging Processors, Light Sources & Accessories for the upper and lower GI. Coordinating development activities of an international & interdisciplinary multi-site team. Initiating new product ideas and new technical approaches.

• Genewave - Manager R&D - IVD Development & Engineering

  2009 - 2011 Responsible for the Development & Engineering Department. QMS Implementation of Design Control.
  
  Genewave develops, manufactures and markets cutting-edge microarray instrumentation for the Molecular Diagnostic & Life Sciences markets.
  The Molecular Diagnostic market is addressed thanks to the GeneSpress® Platform that allows for a fast (2 hours), automated and multiplexed (up to 50 markers) analysis of a biological sample. Genewave is developing two diagnostics kits aimed at helping health professionals to fight Antibiotics Resistance.
  For the Life Science market, Genewave has developed two instruments that are in use by researchers and scientists across the world:
  - HybLIVE which is a fully automated real-time microarray hybridization imaging system,
  - DropLIVE is a real time amplification platform for low volume (1µL) applications

• Genewave - R&D Project Manager

  2006 - 2009

Formations

• Université Paris Nord-Paris 13

  Villetaneuse 2002 - 2006 Doctorat
  
  The purpose of this work was to conceive and to achieve a clinical prototype for early endoscopic in-vivo imaging detection of bladder carcinomas. The principle is to excite the fluorescence of molecules naturally present in the tissue with 308 nm laser pulses. The weak emitted signal is collected by a catheter entirely conceived in the laboratory and which is able to transmit UV images. The fluor

• Conservatoire National Des Arts Et Métiers - Université Paris 13

  Paris 2001 - 2002 DEA

• Université Paris 6 Pierre Et Marie Curie DEA de physique théorique

  Paris 2000 - 2001 Maîtrise

Réseau

Pas de contact professionnel